Search results

Found 8,768 pages
AUTHOR: Selina Mckee

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

AstraZeneca sheds Seroquel rights

AstraZeneca has sold off certain rights to its antipsychotics Seroquel and Seroquel XR in certain territories - including the UK – to Luye Pharma. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/astrazeneca_sheds_seroquel_rights_1234663

PharmaTimes unveils winners of MSEA 2019

This year's competition welcomed a fantastic spread of companies as well as a higher number of entrants - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/pharmatimes_unveils_winners_of_msea_2019_1319263

US approves Merck’s Ebola vaccine

The approval marks a "significant milestone in Ebola prepardness and prevention" - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/us_approves_mercks_ebola_vaccine_1320832

CR UK pairs with Abcam

The partnership will develop and commercialise novel custom antibodies for cancer research - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/cr_uk_pairs_with_abcam_1344454

Boehringer buys ViraTherapeutics

Boehringer Ingelheim has exercised an option to acquire all shares of oncolytic virus company ViraTherapeutics. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/boehringer_buys_viratherapeutics_1252039

US regulators reject Valeant’s Duobrii

The US Food and Drug Administration has rejected Valeant group Ortho Dermatologics’ plaque psoriasis therapy Duobrii. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/us_regulators_reject_valeants_duobrii_1240725

GW completes Epidiolex submission

GW Pharmaceuticals and its US subsidiary Greenwich Biosciences have completed the rolling submission of Epidiolex as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two difficult-to-treat forms of

by Selina McKee

www.pharmatimes.com/news/gw_completes_epidiolex_submission_1209905

NICE links with EMIG

The National Institute for Health and Care Excellence and the Ethical Medicines Industry Group (EMIG) are working together to increase understanding of the services the Institute offers the life sciences industry. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/nice_links_with_emig_1276689

Merck invests in Moderna

Merck is investing $125 million in Moderna under a new deal that expands the firms’ 2016 partnership to develop messenger RNA cancer vaccines. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/merck_invests_in_moderna_1234371

FDA rejects Sunovion’s ADHD drug

Sunovion’s application to market dasotraline for the treatment of attention-deficit hyperactivity disorder (ADHD) has been rejected by US regulators. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/fda_rejects_sunovions_adhd_drug_1251093

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download